Factors affecting the Turnaround Time for Manufacturing, Testing and Release of Cellular Therapy Products prepared at Multiple Sites in support of Multicenter Cardiovascular Regenerative Medicine Protocols – a Cardiovascular Cell Therapy Research Network (CCTRN) Study

BACKGROUND: Cellular therapy studies are often conducted at multiple clinical sites in order to accrue larger patient numbers. In many cases this necessitates use of localized Good Manufacturing Practices (GMP) facilities to supply the cells. To assure consistent quality, oversight by a quality assu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Richman, Sara, Gee, Adrian P., McKenna, David, Traverse, Jay, Henry, Timothy, Fisk, Diann, Pepine, Carl, Bloom, Jeannette, Willerson, James, Prater, Karen, Zhao, David, Koç, Jane Reese, Anwaruddian, Saif, Taylor, Doris, Cogle, Christopher, Moyé, Lemuel, Simari, Robert, Skarlatos, Sonia
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355200/
https://ncbi.nlm.nih.gov/pubmed/22320233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2011.03543.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados